Log in to search using one of your social media accounts:

 

The immunogenetics of Neurological Disease.

This article is protected by copyright. All rights reserved. PMID: 29159928 [PubMed - as supplied by publisher]
Source: Immunology - Category: Allergy & Immunology Authors: Tags: Immunology Source Type: research

Related Links:

CONCLUSIONS: The mean diameter of the jugular veins was 8.7 mm. Internal jugular veins with cylindrical morphology have a diameter smaller than other forms; this difference is statistically significant. The different morphology of the jugular vein confluence does not increase the possibility of a reflux because the positive Valsalva maneuvers are not statistically significant when compared to the various types. KEY WORDS: CCSVI, EchoColorDoppler Map, Jugulo-Subclavian Confluence Diameter. PMID: 29339583 [PubMed - in process]
Source: Annali Italiani di Chirurgia - Category: Surgery Tags: Ann Ital Chir Source Type: research
This study provides the largest and most comprehensive survey to-date of users of consumer tDCS devices. Obtaining a deeper knowledge of what drives home users—to purchase and use a consumer tDCS device (or for many, to cease to use it)—has important implications, both for ongoing debates about the ethical implications of the home use of tDCS, as well as for discussions of the regulation of direct-to-consumer neurotechnology. Thus, the present study not only provides an empirical foundation on which to base policy recommendations, but also offers a concrete, empirical perspective on a debate that has too-often ...
Source: SharpBrains - Category: Neuroscience Authors: Tags: Cognitive Neuroscience Health & Wellness Technology brain-stimulation Consumer neurotechnology Direct-to-consumer neuroscience do it yourself Neuroethics non-invasive tDCS Transcranial-direct-current-stimulation Source Type: blogs
Conclusions: Most respondents reported both speech and language symptoms, and many experienced restricted communicative participation. Access to speech-language pathology services is still inadequate. Services should also address cognitive/linguistic aspects to meet the needs of people with PD.Folia Phoniatr Logop 2017;69:131 –141
Source: Folia Phoniatrica et Logopaedica - Category: Speech-Language Pathology Source Type: research
Conditions:   Dementia;   Dementia Alzheimers;   Dementia, Vascular;   Dementia, Mixed Intervention:   Other: No interventions Sponsors:   University of Michigan;   National Institutes of Health (NIH) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Condition:   Dementia Intervention:   Sponsors:   McGill University;   Canadian Institutes of Health Research (CIHR);   Alzheimer Society of Canada;   Sanofi;   New Brunswick Health Research Foundation;   Saskatchewan Health Research Foundation;   Women's Brain Health Initiative;   Michael Smith Foundation for Heal th Research;   Alzheimer's Research UK;   Alberta Prion Research Institute;   Nova Scotia Hea...
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Condition:   Alzheimer Disease Interventions:   Drug: neflamapimod;   Other: placebo Sponsors:   EIP Pharma, LLC;   Worldwide Clinical Trials;   VU University Medical Center Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Condition:   Alzheimer Disease Interventions:   Drug: Montelukast new buccal film;   Other: Placebo buccal film Sponsor:   IntelGenx Corp. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Coordinating Alzheimer ’s care for your parent is difficult, and the last thing you want is to have to deal with a financial hardship. Elder care is expensive. Begin to secure the support necessary to keep your parent happy and healthy by taking these steps. Assets and income: As precisely as possible, estimate your parent or parents’ net wealth and income. This means considering the total value of their home, their bank accounts, investment funds or individual investments they own, and income…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Source Type: news
Authors: Wang KK, Yang Z, Zhu T, Shi Y, Rubenstein R, Tyndall JA, Manley GT Abstract INTRODUCTION: Traumatic brain injury (TBI) is a major worldwide neurological disorder of epidemic proportions. To date, there are still no FDA-approved therapies to treat any forms of TBI. Encouragingly, there are emerging data showing that biofluid-based TBI biomarker tests have the potential to diagnose the presence of TBI of different severities including concussion, and to predict outcome. Area covered: The authors provide an update on the current knowledge of TBI biomarkers, including protein biomarkers for neuronal cell body ...
Source: Expert Review of Molecular Diagnostics - Category: Laboratory Medicine Tags: Expert Rev Mol Diagn Source Type: research
Authors: Buckley PF PMID: 29341823 [PubMed - in process]
Source: Clinical Schizophrenia and Related Psychoses - Category: Psychiatry Tags: Clin Schizophr Relat Psychoses Source Type: research
More News: Allergy & Immunology | ALS | Alzheimer's | Brain | Environmental Health | Genetics | Multiple Sclerosis | Myasthenia Gravis | Neurology | Parkinson's Disease | Schizophrenia | Study